Harold Baer
Nephrology · Bakersfield, CANPI 1649382920
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.5% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AstraZeneca at 25.1% of the total. Reporting peaked in 2021 at $1,290 and has fallen 78.7% since, to $275 in 2022.
Across 129 payments — averaging $24.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$801
- Amgen$635
- Bayer$355
- Otsuka America Pharmaceutical, Inc.$265
- Daiichi Sankyo Inc.$238
- Fresenius USA Marketing, Inc.$234
- plus $663 from 12 others
What the payments were for
- Food & beverage$3,08097%
- Education$1113%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 27 | $801 |
| Amgen(2 entities) | 25 | $635 |
| Bayer | 11 | $355 |
| Otsuka America Pharmaceutical, Inc. | 10 | $265 |
| Daiichi Sankyo Inc. | 12 | $238 |
| Fresenius USA Marketing, Inc. | 18 | $234 |
| Novartis | 2 | $149 |
| Vifor Pharma, Inc. | 8 | $138 |
| Akebia Therapeutics Inc | 6 | $122 |
| Angiodynamics, Inc. | 1 | $91 |
| Sanofi | 2 | $38 |
| Aurinia Pharma U.S., Inc. | 1 | $29 |
| Mallinckrodt Hospital Products Inc. | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Novo Nordisk | 1 | $15 |
| OPKO Pharmaceuticals, LLC | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Xeris Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,191 in reported general payments places this provider in the 70th percentile of 1,341 nephrology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 12 | $195 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Bakersfield
- Hashim KazmiBakersfield$99K
- Anjay RastogiLos Angeles$2.2M
- Glenn ChertowStanford$2M
- Luis AlvarezPalo Alto$1.8M
- Jose MorfinSacramento$1M
- Rodolfo BatarseRancho Mirage$910K
- Vandana MathurWoodside$769K
- Yasir QaziOrange$618K
- Rafael VillicanaLoma Linda$610K
- Sunil PatelApple Valley$509K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.